252 related articles for article (PubMed ID: 14578862)
61. [Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer].
Isshiki K; Nonami T; Kishimoto W; Katoh H; Akaza K; Harada A; Nakao A; Takagi H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1634-7. PubMed ID: 2167638
[TBL] [Abstract][Full Text] [Related]
62. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
[TBL] [Abstract][Full Text] [Related]
63. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
64. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
65. [131-I-lipiodol in therapy of liver carcinoma--methods and case report].
Stefanović L; Nikolić V; Obradović M; Selir Z; Mihoci Z; Mihailović J; Malesević M
Med Pregl; 2001; 54(7-8):387-90. PubMed ID: 11905192
[TBL] [Abstract][Full Text] [Related]
66. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
[TBL] [Abstract][Full Text] [Related]
67. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
[TBL] [Abstract][Full Text] [Related]
68. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
69. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients.
Tralhão JG; Dagher I; Lino T; Roudié J; Franco D
Eur J Surg Oncol; 2007 Aug; 33(6):746-51. PubMed ID: 17188454
[TBL] [Abstract][Full Text] [Related]
70. The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study.
Mizuta T; Ozaki I; Eguchi Y; Yasutake T; Kawazoe S; Fujimoto K; Yamamoto K
Cancer; 2006 Feb; 106(4):867-72. PubMed ID: 16400650
[TBL] [Abstract][Full Text] [Related]
71. Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.
Bernal P; Raoul JL; Vidmar G; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Stare J; Buscombe J; Minh CT; Saw MM; Chen S; Ogbac R; Padhy AK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1448-55. PubMed ID: 17692473
[TBL] [Abstract][Full Text] [Related]
72. [Value of perioperative adjuvant therapy in liver transplantation for advanced hepatocellular carcinoma].
Sun J; Hou BH; Jian ZX; Ou YL; Ou JR
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):471-3. PubMed ID: 17545034
[TBL] [Abstract][Full Text] [Related]
73. Hepatic resection for hepatocellular carcinoma in elderly patients.
Yeh CN; Lee WC; Jeng LB; Chen MF
Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
[TBL] [Abstract][Full Text] [Related]
74. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus.
Peng B; Liang L; He Q; Zhou F; Luo S
Hepatogastroenterology; 2006; 53(69):415-9. PubMed ID: 16795984
[TBL] [Abstract][Full Text] [Related]
75. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
76. Better survival in women than in men after radical resection of hepatocellular carcinoma.
Nagasue N; Galizia G; Yukaya H; Kohno H; Chang YC; Hayashi T; Nakamura T
Hepatogastroenterology; 1989 Oct; 36(5):379-83. PubMed ID: 2559886
[TBL] [Abstract][Full Text] [Related]
77. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.
Lang H; Sotiropoulos GC; Brokalaki EI; Schmitz KJ; Bertona C; Meyer G; Frilling A; Paul A; Malagó M; Broelsch CE
J Am Coll Surg; 2007 Jul; 205(1):27-36. PubMed ID: 17617329
[TBL] [Abstract][Full Text] [Related]
78. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
79. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
Lau WY; Leung TW; Ho SK; Chan M; Machin D; Lau J; Chan AT; Yeo W; Mok TS; Yu SC; Leung NW; Johnson PJ
Lancet; 1999 Mar; 353(9155):797-801. PubMed ID: 10459961
[TBL] [Abstract][Full Text] [Related]
80. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
